文献速递新生儿儿童感染

莫匹罗星用于新生儿重症监护病房婴儿金黄色葡萄球菌去定植

Mupirocin for Staphylococcus aureus Decolonization of Infants in Neonatal Intensive Care Units.
PubMed 文献 · Pediatrics · 2019-01-01

该2期多中心开放标签随机试验纳入155例鼻部金黄色葡萄球菌定植的NICU婴儿,评估鼻内联合局部涂抹莫匹罗星5天的安全性和去定植效果。结果显示莫匹罗星组第8天原发去定植率93.9%显著高于对照组4.7%(P<.001),但第22天持续去定植率仅45.7%,且皮疹(多为轻度肛周)在治疗组更常见。

要点

  • 莫匹罗星多部位涂抹5天可安全有效清除NICU婴儿金黄色葡萄球菌定植。
  • 第8天去定植率93.9% vs 4.7%(P<.001),但第22天降至45.7%。
  • 治疗组皮疹(多为轻度肛周)发生率显著高于未治疗组。

核心结论

  • 莫匹罗星多部位涂抹可安全有效地清除NICU婴儿金黄色葡萄球菌定植,但2-3周后许多仍住院婴儿出现再定植。

研究设计与样本

  • 2期多中心开放标签随机试验,2014年4月至2016年5月8个中心NICU中<24月龄婴儿经系列鼻部筛查,定植且符合条件者随机接受5天莫匹罗星或不用莫匹罗星涂抹鼻内、脐周和肛周。

主要发现

  • 共155例婴儿随机分组;莫匹罗星总体耐受良好,但皮疹(通常轻度且位于肛周)在治疗组显著多于未治疗组。
  • 第8天原发去定植:治疗组62/66(93.9%)vs 对照组3/64(4.7%),P<.001。

关键数值与推荐

  • 原发去定植定义为第8天三个部位均去定植,治疗组93.9% vs 对照组4.7%(P<.001)。
  • 持续去定植定义为第22天三个部位均去定植,治疗组45.7% vs 对照组2.1%(P<.001)。

临床怎么用

  • 对NICU鼻部金黄色葡萄球菌定植婴儿可考虑使用5天莫匹罗星多部位涂抹以短期去定植。
  • 需注意治疗组皮疹(多为轻度肛周)更常见,且2-3周后可能再定植。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: : media-1vid110.1542/5849573989001PEDS-VA_2018-1565Video Abstract BACKGROUND AND OBJECTIVES: Staphylococcus aureus (SA) is the second leading cause of late-onset sepsis among infants in the NICU. Because colonization of nasal mucosa and/or skin frequently precedes invasive infection, decolonization strategies, such as mupirocin application, have been attempted to prevent clinical infection, but data supporting this approach in infants are limited. We conducted a phase 2 multicenter, open-label, randomized trial to assess the safety and efficacy of intranasal plus topical mupirocin in eradicating SA colonization in critically ill infants. METHODS: Between April 2014 and May 2016, infants <24 months old in the NICU at 8 study centers underwent serial screening for nasal SA. Colonized infants who met eligibility criteria were randomly assigned to receive 5 days of mupirocin versus no mupirocin to the intranasal, periumbilical, and perianal areas. Mupirocin effects on primary (day 8) and persistent (day 22) decolonization at all three body sites were assessed. RESULTS: A total of 155 infants were randomly assigned. Mupirocin was generally well tolerated, but rashes (usually mild and perianal) occurred significantly more often in treated versus untreated infants. Primary decolonization occurred in 62 of 66 (93.9%) treated infants and 3 of 64 (4.7%) control infants (P < .001). Twenty-one of 46 (45.7%) treated infants were persistently decolonized compared with 1 of 48 (2.1%) controls (P < .001). CONCLUSIONS: Application of mupirocin to multiple body sites was safe and efficacious in eradicating SA carriage among infants in the NICU; however, after 2 to 3 weeks, many infants who remained hospitalized became recolonized.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Kotloff KL, Shirley DT, Creech CB, et al. Mupirocin for Staphylococcus aureus Decolonization of Infants in Neonatal Intensive Care Units. Pediatrics. 2019. PMID: 30587533. doi:10.1542/peds.2018-1565

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。